Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Breast Neoplasms 167 Neoplasms 30 Neoplasm Metastasis 29 Brain Neoplasms 16 Breast Neoplasms, Male 15 Head and Neck Neoplasms 8 Urinary Bladder Neoplasms 7 Stomach Neoplasms 7 Squamous Cell Carcinoma of Head and Neck 6 Ovarian Neoplasms 6 Colorectal Neoplasms 6 Prostatic Neoplasms 5 Inflammatory Breast Neoplasms 5 Glioblastoma 5 Carcinoma, Non-Small-Cell Lung 5 Esophageal Neoplasms 4 Carcinoma, Ovarian Epithelial 4 Unspecified Adult Solid Tumor, Protocol Specific 3 Salivary Gland Neoplasms 3 Recurrence 3 Pancreatic Neoplasms 3 Lung Neoplasms 3 Gliosarcoma 3 Glioma 3 Gallbladder Neoplasms 3 Ependymoma 3 Carcinoma, Squamous Cell 3 Triple Negative Breast Neoplasms 2 Solid Tumors 2 Osteitis Deformans 2

Interventions

Doxorubicin 142 Ifosfamide 85 Radiotherapy 82 Cyclophosphamide 72 Gemcitabine 63 Filgrastim 54 pembrolizumab 43 pazopanib 40 Etoposide 39 Docetaxel 39 Vincristine 37 Trabectedin 37 Cisplatin 35 Nivolumab 32 Magnetic Resonance Spectroscopy 26 Irinotecan 26 Carboplatin 25 Surgical Procedures, Operative 24 Temozolomide 23 Radiation 22 Ipilimumab 22 Bevacizumab 20 Blood Specimen Collection 19 Granulocyte Colony-Stimulating Factor 18 Biopsy 18 eribulin 17 anlotinib 17 Sirolimus 17 Mesna 17 Melphalan 17

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Sarcoma × Lapatinib × Clear all

NCT03784014 2026-04-29

MULTISARC

Institut National de la Santé Et de la Recherche Médicale, France

Phase 3 Completed

Neoplasm Metastasis, Sarcoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡